Published in Stem Cells on October 01, 2013
Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol (2015) 1.17
Adverse fibrosis in the aging heart depends on signaling between myeloid and mesenchymal cells; role of inflammatory fibroblasts. J Mol Cell Cardiol (2013) 0.96
Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int (2014) 0.96
Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol (2015) 0.84
Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4. Am J Transl Res (2015) 0.82
Altering the response to radiation: sensitizers and protectors. Semin Oncol (2014) 0.81
Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells. Leukemia (2016) 0.80
IL-13 is a therapeutic target in radiation lung injury. Sci Rep (2016) 0.78
A Co-Culture Model of Fibroblasts and Adipose Tissue-Derived Stem Cells Reveals New Insights into Impaired Wound Healing After Radiotherapy. Int J Mol Sci (2015) 0.76
Therapeutic potential of gingival fibroblasts for cutaneous radiation syndrome: comparison to bone marrow-mesenchymal stem cell grafts. Stem Cells Dev (2015) 0.76
The efficacy of human placenta-derived mesenchymal stem cells on radiation enteropathy along with proteomic biomarkers predicting a favorable response. Stem Cell Res Ther (2017) 0.75
Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury. Stem Cells Transl Med (2016) 0.75
Neupogen and mesenchymal stem cells are novel therapeutic agents in regeneration of induced endometrial fibrosis in experimental rats. Biosci Rep (2017) 0.75
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol (2008) 10.13
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res (2011) 9.03
Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol (2004) 3.58
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go? Nat Clin Pract Oncol (2006) 2.97
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. J Clin Oncol (2005) 2.36
Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Mol Cell (2010) 2.24
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias. Blood (2007) 2.15
CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma. Clin Cancer Res (2010) 1.92
Role of type II pneumocyte senescence in radiation-induced lung fibrosis. J Natl Cancer Inst (2013) 1.64
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A (2012) 1.38
Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. Mol Cell (2012) 1.35
The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells. Cancer Res (2003) 1.35
A method of high frequency virus-induced gene silencing in chili pepper (Capsicum annuum L. cv. Bukang). Mol Cells (2004) 1.32
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies. Clin Cancer Res (2007) 1.27
Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain. Nat Struct Mol Biol (2009) 1.22
Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. Cancer Cell (2013) 1.08
A phase II study of perifosine in androgen independent prostate cancer. Cancer Biol Ther (2005) 1.04
Clinical biomarkers of angiogenesis inhibition. Cancer Metastasis Rev (2008) 0.98
Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. J Biol Chem (2009) 0.97
Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses. Arch Dermatol (2011) 0.96
Tonic spasms in acute transverse myelitis. J Clin Neurosci (2008) 0.93
Surgical management of melanoma brain metastases in patients treated with immunotherapy. J Neurosurg (2011) 0.91
Characterization of the interaction of Aha1 with components of the Hsp90 chaperone machine and client proteins. Biochim Biophys Acta (2012) 0.90
Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition. Clin Cancer Res (2011) 0.89
MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer. BMC Cancer (2014) 0.89
Transforming growth factor alpha is a critical mediator of radiation lung injury. Radiat Res (2014) 0.87
Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens. Biomark Med (2014) 0.86
Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies. Radiat Oncol (2012) 0.86
Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer. BMC Cancer (2014) 0.85
Novel SGCE gene mutation in a Korean patient with myoclonus-dystonia with unique phenotype mimicking Moya-Moya disease. Mov Disord (2007) 0.85
Evaluation of the fullerene compound DF-1 as a radiation protector. Radiat Oncol (2010) 0.84
Quercetin inhibits radiation-induced skin fibrosis. Radiat Res (2013) 0.84
Sequential observation of movement disorders and brain images in the case of central pontine myelinolysis and extrapontine myelinolysis. Parkinsonism Relat Disord (2006) 0.84
The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models. Neurol Res (2007) 0.83
Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease. Mov Disord (2007) 0.83
Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: analysis of [11C] raclopride PET study. Mov Disord (2008) 0.83
Corrected QT Interval Prolongation during Severe Hypoglycemia without Hypokalemia in Patients with Type 2 Diabetes. Diabetes Metab J (2013) 0.82
The role of S100A14 in epithelial ovarian tumors. Oncotarget (2014) 0.81
Histone deacetylase inhibitors induce apoptosis with minimal viral reactivation in cells infected with Kaposi's sarcoma-associated herpesvirus. J Invest Dermatol (2006) 0.81
Multimodal management of muscle-invasive bladder cancer. Curr Probl Cancer (2014) 0.81
Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy. Mov Disord (2006) 0.80
Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer. Pathobiology (2015) 0.80
Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation. Cancer (2014) 0.80
A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses. Peptides (2013) 0.79
Peptidases released by necrotic cells control CD8+ T cell cross-priming. J Clin Invest (2013) 0.79
Post-collection, pre-measurement variables affecting VEGF levels in urine biospecimens. J Cell Mol Med (2008) 0.79
Differential inhibition of Hsc70 activities by two Hsc70-binding peptides. Biochemistry (2002) 0.78
Inhibition of radiation-induced skin fibrosis with imatinib. Int J Radiat Biol (2012) 0.78
Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism. J Clin Neurol (2005) 0.77
MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands. Int J Oncol (2013) 0.77
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost. Radiat Oncol (2006) 0.77
Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide. Mov Disord (2006) 0.76
Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Genes Chromosomes Cancer (2014) 0.76
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists. Mov Disord (2006) 0.76
Peripheral nerve axon involvement in myotonic dystrophy type 1, measured using the automated nerve excitability test. J Clin Neurol (2011) 0.76
Molecular characterization of Clonorchis sinensis tetraspanin 2 extracellular loop 2. Parasitol Res (2011) 0.76
Research highlights. Biomark Med (2009) 0.75